224th ENMC International Workshop:

Neuromuscular Disorders - Tập 28 Số 1 - Trang 87-99 - 2018
Yves Allenbach1,2, Andrew L. Mammen3, Olivier Benveniste1,2, Werner Stenzel4, Anthony A. Amato, Audrey Aussey, Jan De Bleecker5, Ingrid de Groot, Marjolein Visser5, Hans H. Goebel, B. Hervier1, Norina Fischer6,7,8,9, David Hilton‐Jones5, Janine A. Lamb, Ingrid E. Lundberg, Tahseen Mozaffar10, Ichizo Nishino11, Alan Pestronk12, Ulrike Schara13, Werner Stenzelr4
1CHU Pitié-Salpêtrière [AP-HP]
2Centre de recherche en Myologie – U974 SU-INSERM
3National Institutes of Health, Bethesda, MD, USA
4Department of Neuropathology, Charité-Universitätsmedizin, Berlin, Germany
5Department of Neurology
6Berlin Institute of Health
7Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
8Freie Universität Berlin
9Humboldt-Universität zu Berlin = Humboldt University of Berlin = Université Humboldt de Berlin
10University of California, Irvine
11National Center of Neurology and Psychiatry, Tokyo, Japan
12Washington University in Saint Louis
13Universität Duisburg-Essen = University of Duisburg-Essen [Essen]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Pinal-Fernandez, 2016, Spectrum of immune-mediated necrotizing myopathies and their treatments, Curr Opin Rheumatol, 28, 619, 10.1097/BOR.0000000000000335

Suzuki, 2015, Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients, Orphanet J Rare Dis, 10, 61, 10.1186/s13023-015-0277-y

Suzuki, 2008, Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies, Rheumatology, 47, 1539, 10.1093/rheumatology/ken325

Suzuki, 2012, Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome, Arch Neurol, 69, 728, 10.1001/archneurol.2011.1728

Targoff, 1990, Antibody to signal recognition particle in polymyositis, Arthritis Rheum, 33, 1361, 10.1002/art.1780330908

Watanabe, 2016, Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy, J Neurol Neurosurg Psychiatry, 87, 1038, 10.1136/jnnp-2016-313166

Benveniste, 2011, Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis Rheum, 63, 1961, 10.1002/art.30344

Allenbach, 2016, High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody, Brain, 139, 2131, 10.1093/brain/aww054

Pinal-Fernandez, 2017, Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity, Ann Rheum Dis, 76, 681, 10.1136/annrheumdis-2016-210198

Needham, 2007, Progressive myopathy with up-regulation of MHC-I associated with statin therapy, Neuromuscul Disord, 17, 194, 10.1016/j.nmd.2006.10.007

Grable-Esposito, 2010, Immune-mediated necrotizing myopathy associated with statins, Muscle Nerve, 41, 185, 10.1002/mus.21486

Christopher-Stine, 2010, A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy, Arthritis Rheum, 62, 2757, 10.1002/art.27572

Mammen, 2011, Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy, Arthritis Rheum, 63, 713, 10.1002/art.30156

Werner, 2012, Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Arthritis Rheum, 64, 4087, 10.1002/art.34673

Allenbach, 2014, Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin, Medicine (Baltimore), 93, 150, 10.1097/MD.0000000000000028

Ge, 2015, Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies, PLoS ONE, 10, 10.1371/journal.pone.0141616

Musset, 2016, Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study, Autoimmun Rev, 15, 983, 10.1016/j.autrev.2016.07.023

Kadoya, 2016, Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy, Neurol Neuroimmunol Neuroinflamm, 3, e290, 10.1212/NXI.0000000000000290

Limaye, 2015, Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase in patients with immune-mediated myositis and necrotizing myopathy, Muscle Nerve, 52, 196, 10.1002/mus.24541

Tsujikawa, 2016, HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma, Neurology, 87, 841, 10.1212/WNL.0000000000003006

Troyanov, 2005, Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients, Medicine (Baltimore), 84, 231, 10.1097/01.md.0000173991.74008.b0

Zahr, 2011, Malignancy in myositis, Curr Rheumatol Rep, 13, 208, 10.1007/s11926-011-0169-7

Wang, 2014, Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients, Neuromuscul Disord, 24, 335, 10.1016/j.nmd.2014.01.002

Smith, 1969, Skeletal muscle necrosis associated with carcinoma, J Pathol, 97, 207, 10.1002/path.1710970204

Levin, 1998, Paraneoplastic necrotizing myopathy: clinical and pathological features, Neurology, 50, 764, 10.1212/WNL.50.3.764

Reeves, 1986, Human autoantibodies reactive with the signal-recognition particle, Proc Natl Acad Sci USA, 83, 9507, 10.1073/pnas.83.24.9507

Hoogendijk, 2004, 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands, Neuromuscul Disord, 14, 337, 10.1016/j.nmd.2004.02.006

Tiniakou, 2017, Idiopathic inflammatory myopathies and malignancy: a comprehensive review, Clin Rev Allergy Immunol, 52, 20, 10.1007/s12016-015-8511-x

Allenbach, 2017, Integrated classification of inflammatory myopathies, Neuropathol Appl Neurobiol, 43, 62, 10.1111/nan.12380

Emslie-Smith, 1991, Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration, Neurology, 41, 936, 10.1212/WNL.41.6.936

Pinal-Fernandez, 2015, The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis, J Rheumatol, 42, 1448, 10.3899/jrheum.141443

Chung, 2015, The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy, Muscle Nerve, 52, 189, 10.1002/mus.24642

Pestronk, 2011, Acquired immune and inflammatory myopathies: pathologic classification, Curr Opin Rheumatol, 23, 595, 10.1097/BOR.0b013e32834bab42

Miller, 2002, Myopathy with antibodies to the signal recognition particle: clinical and pathological features, J Neurol Neurosurg Psychiatry, 73, 420, 10.1136/jnnp.73.4.420

Pestronk, 2006, Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features, Arthritis Rheum, 54, 1687, 10.1002/art.21822

Noguchi, 2017, Skeletal muscle involvement in antisynthetase syndrome, JAMA Neurol, 74, 992, 10.1001/jamaneurol.2017.0934

Basharat, 2016, Statin-induced anti-HMGCR-associated myopathy, J Am Coll Cardiol, 68, 234, 10.1016/j.jacc.2016.04.037

Brink, 2013, Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis, Arthritis Rheum, 65, 899, 10.1002/art.37835

Klareskog, 2006, A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination, Arthritis Rheum, 54, 38, 10.1002/art.21575

de Hair, 2013, Smoking and overweight determine the likelihood of developing rheumatoid arthritis, Ann Rheum Dis, 72, 1654, 10.1136/annrheumdis-2012-202254

Mankia, 2016, Preclinical rheumatoid arthritis: progress toward prevention, Arthritis Rheumatol, 68, 779, 10.1002/art.39603

Klareskog, 2009, Rheumatoid arthritis, Lancet, 373, 659, 10.1016/S0140-6736(09)60008-8

Chinoy, 2012, Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study, Ann Rheum Dis, 71, 961, 10.1136/annrheumdis-2011-200182

Mammen, 2012, Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects, Arthritis Care Res (Hoboken), 64, 269, 10.1002/acr.20662

Arouche-Delaperche, 2017, Pathogenic role of anti-SRP and anti-HMGCR antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies, Ann Neurol, 81, 538, 10.1002/ana.24902

Betteridge, 2016, Myositis-specific autoantibodies: an important tool to support diagnosis of myositis, J Intern Med, 280, 8, 10.1111/joim.12451

Jia, 2013, Imputing amino acid polymorphisms in human leukocyte antigens, PLoS ONE, 8

Rothwell, 2016, Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups, Ann Rheum Dis, 75, 1558, 10.1136/annrheumdis-2015-208119

Candore, 2002, Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions, Autoimmun Rev, 1, 29, 10.1016/S1568-9972(01)00004-0

Mammen, 2012, Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Arthritis Care Res (Hoboken), 64, 1233, 10.1002/acr.21671

Group, 2008, SLCO1B1 variants and statin-induced myopathy—a genomewide study, N Engl J Med, 359, 789, 10.1056/NEJMoa0801936

Kassardjian, 2015, Clinical features and treatment outcomes of necrotizing autoimmune myopathy, JAMA Neurol, 72, 996, 10.1001/jamaneurol.2015.1207

Ramanathan, 2015, Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy, Neurol Neuroimmunol Neuroinflamm, 2, e96, 10.1212/NXI.0000000000000096

Mammen, 2015, Intravenous immune globulin for statin-triggered autoimmune myopathy, N Engl J Med, 373, 1680, 10.1056/NEJMc1506163

Valiyil, 2010, Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series, Arthritis Care Res (Hoboken), 62, 1328, 10.1002/acr.20219

Condon, 2013, Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids, Ann Rheum Dis, 72, 1280, 10.1136/annrheumdis-2012-202844

Tiniakou, 2017, More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Rheumatology, 56, 787